These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 5080345)

  • 41. [A case of chloroquine-induced porphyrinuria].
    Knutsson F; Lindstedt G; Norrby A; Rödjer S
    Lakartidningen; 1973 Apr; 70(15):1547-8. PubMed ID: 4697903
    [No Abstract]   [Full Text] [Related]  

  • 42. [Therapy of porphyria cutanea tarda using chloroquine].
    Horkay I; Nagy E
    Z Hautkr; 1978 Jun; 53(12):417-21. PubMed ID: 676418
    [No Abstract]   [Full Text] [Related]  

  • 43. [Experience with the therapy of symptomatic liver porphyria using a combination of antimalarial agents--chloroquine with pyrimethamine].
    Zoubek V; Martásek P; Kordac V
    Cas Lek Cesk; 1987 Feb; 126(6):170-3. PubMed ID: 3815471
    [No Abstract]   [Full Text] [Related]  

  • 44. Biochemical effects of phlebotomy treatment on experimental porphyria in rats.
    Nozicková M
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl; 1973; 16(3):241-5. PubMed ID: 4528445
    [No Abstract]   [Full Text] [Related]  

  • 45. Porphyria variegata: failure of chloroquin treatment.
    Cramers M; Jepsen LV
    Acta Derm Venereol; 1980; 60(1):89-91. PubMed ID: 6153849
    [TBL] [Abstract][Full Text] [Related]  

  • 46. An unusual reaction to chloroquine-primaquine.
    Thornsvard CT; Guider BA; Kimball DB
    JAMA; 1976 Apr; 235(16):1719-20. PubMed ID: 946467
    [No Abstract]   [Full Text] [Related]  

  • 47. [Results of treatment of porphyria cutanea tarda with bloodletting and chloroquine].
    Seubert S; Seubert A; Stella AM; Guzman H; Batlle A
    Z Hautkr; 1990 Mar; 65(3):223-5. PubMed ID: 2339575
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Porphyria cutanea tarda treated with low doses of antimalarial agents; liver findings (author's transl)].
    Chlumský J; Dobiás J; Chlumská A; Malina L
    Cas Lek Cesk; 1977 Nov; 116(45):1404-6. PubMed ID: 603887
    [No Abstract]   [Full Text] [Related]  

  • 49. Long-term effect of high-dose, short-course chloroquine therapy on porphyria cutanea tarda.
    Tsega E
    Q J Med; 1987 Nov; 65(247):953-7. PubMed ID: 3455550
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Comparative evaluation of the therapeutic effectiveness of small and regular doses of delagil in porphyria cutanea tarda].
    Krivosheev BN
    Vestn Dermatol Venerol; 1981 Sep; (9):50-4. PubMed ID: 7029950
    [No Abstract]   [Full Text] [Related]  

  • 51. 17-Oxosteroid control of porphyrin biosynthesis.
    Moore MR; Paxton JW; Beattie AD; Goldberg A
    Enzyme; 1973; 16(1):314-25. PubMed ID: 4791050
    [No Abstract]   [Full Text] [Related]  

  • 52. Porphyria cutanea tarda: clinical and laboratory features.
    Sweeney GD; Jones KG
    Can Med Assoc J; 1979 Apr; 120(7):803-7. PubMed ID: 427687
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Porphyria.
    Wiegand SE
    J Med Assoc Ga; 1972 Mar; 61(3):99-106. PubMed ID: 4551367
    [No Abstract]   [Full Text] [Related]  

  • 54. Ascorbate status of patients with porphyria cutanea tarda symptomatica and its effect on porphyrin metabolism.
    Percy VA; Naidoo D; Joubert SM; Pegoraro RJ
    S Afr J Med Sci; 1975; 40(4):185-96. PubMed ID: 1209393
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [On the biochemical pathogenesis of acute intermittent porphyria].
    Heilmeyer L
    Munch Med Wochenschr; 1969 Apr; 111(16):905-9. PubMed ID: 5819143
    [No Abstract]   [Full Text] [Related]  

  • 56. Deferoxamine in the treatment of porphyria.
    Taxay EP
    South Med J; 1972 Oct; 65(10):1186-212. PubMed ID: 5074089
    [No Abstract]   [Full Text] [Related]  

  • 57. Chloroquine in the treatment of porphyria cutanea tarda.
    Kordac V; Papezová R; Semrádová M
    N Engl J Med; 1977 Apr; 296(16):949. PubMed ID: 846527
    [No Abstract]   [Full Text] [Related]  

  • 58. The reversal of experimental porphyria and the prevention of induction of hepatic mixed-function oxidase by acetate.
    Piper WN; Tephly TR
    Arch Biochem Biophys; 1974 Sep; 164(1):351-6. PubMed ID: 4372951
    [No Abstract]   [Full Text] [Related]  

  • 59. [Experiences with iron elimination therapy in porphyria cutanea tarda].
    Haneke E; Schwartze G
    Z Gesamte Inn Med; 1971 Nov; 26(22):710-6. PubMed ID: 5141034
    [No Abstract]   [Full Text] [Related]  

  • 60. Experimental porphyria induced in rats by hexachlorobenzene. A study of the porphyrins excreted by urine.
    San Martin de Viale LC; Viale AA; Nacht S; Grinstein M
    Clin Chim Acta; 1970 Apr; 28(1):13-23. PubMed ID: 4191620
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.